Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
April 21 (Reuters) - Shenzhen Hepalink Pharmaceutical Group Co Ltd:
* SAYS ITS U.S. UNIT'S JOINT STOCK COMPANY ONCOQUEST INC PLANS TO SELL DRUG-RELATED ASSETS TO SOUTH KOREA'S DUAL INDUSTRIAL CO LTD Source text in Chinese: bit.ly/3cw9gFR Further company coverage: (Reporting by Hong Kong newsroom)
